Value-Based Pricing and Patient Access for Specialty Drugs-Reference-Cited by-同舟云学术

Value-Based Pricing and Patient Access for Specialty Drugs

Published:2018-06-05 Issue:21 Volume:319 Page:2169
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Robinson James C.¹,Howell Scott²,Pearson Steven D.³

Affiliation:

1. University of California, Berkeley

2. Novartis Pharmaceuticals Corp, East Hanover, New Jersey

3. Institute for Clinical and Economic Review, Boston, Massachusetts

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference6 articles.

1. The high cost of prescription drugs in the United States: origins and prospects for reform.;Kesselheim;JAMA,2016

2. Pricing in the market for anticancer drugs.;Howard;J Econ Perspect,2015

3. LangrethR, MigliozziB, GokhaleK. The US pays a lot more for top drugs than other countries. Bloomberg. https://www.bloomberg.com/graphics/2015-drug-prices/. Published December 18, 2015. Accessed February 1, 2018.

4. ClaxtonG, RaeM, LongM, ; Kaiser Family Foundation; Health Research & Educational Trust. Employer health benefits: 2016 annual survey. http://www.kff.org/health-costs/report/2016-employer-health-benefits-survey/. Published September 2016. Accessed January 21, 2018.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost effectiveness of hepatitis C direct acting agents;Expert Review of Pharmacoeconomics & Outcomes Research;2024-05-03

2. ASHP Survey of Health-System Specialty Pharmacy Practice: Practice Models, Operations, and Workforce — 2022;American Journal of Health-System Pharmacy;2023-09-24

3. Scientific Evidence Production and Specialty Drug Diffusion;Journal of Marketing;2023-07-12

4. 2022 ASHP Survey of Health-System Specialty Pharmacy Practice: Clinical Services;American Journal of Health-System Pharmacy;2023-03-31

5. Pharmacy Benefit Management: The Cost of Drug Price Rebates;Journal of Law, Medicine & Ethics;2023